by Amie Ferris-Rotman Tue Jan 30, 11:11 AM ET
LONDON (Reuters) - Human trials of an experimental treatment for obesity derived from cannabis, which is commonly associated with stimulating hunger, are scheduled to begin in the second half of this year, Britain's GW Pharmaceuticals Plc announced...